Habib Dable
InvestorAdvisor at RA Capital
Cambridge, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Habib
262 people in our graph share verified history with Habib — schools, employers, funds. One of them is your warm intro.
Dan LynchunlockedHabib: together at Blueprint Medicines (2022–2025)
Habib: together at Day One Biopharmaceuticals
×2Habib: together at RA Capital
×7Habib: together at Bayer
About
Habib Dable is an Advisor at Raven, where he advises and supports new companies, portfolio companies, and executives. He previously spent five years as President and CEO of Acceleron Pharma, which was acquired by Merck in 2021, and earlier held leadership roles over roughly 22 years at Bayer AG, including President, U.S. Pharmaceuticals. He holds a BBA and MBA from the University of New Brunswick and completed executive programs at Stanford University and Korn/Ferry.
Invests in
Biotech
Experience
- RA Capital Management, L.P.Advisorcurrent2022 — presentBoston, Massachusetts, United States
- Atavistik BioBoard Membercurrent2026 — presentCambridge, Massachusetts, United States
- Tyra BiosciencesIndependent Board Directorcurrent2026 — presentCarlsbad, California, United States
- SpyGlass Pharma, Inc.Independent Board Directorcurrent2026 — presentIrvine, California, United States
- Relay TherapeuticsIndependent Board Directorcurrent2025 — presentCambridge, Massachusetts, United States
- PepGenIndependent Board Directorcurrent2022 — presentCambridge, Massachusetts, United States
- BIOLINK.orgBoard Membercurrent2022 — present
- Day One BiopharmaceuticalsIndependent Board Director2024 — 2026Brisbane, California, United States
- Blueprint MedicinesIndependent Board Director2022 — 2025Cambridge, Massachusetts, United States
- Aerovate Therapeutics, Inc.Board Chair2024 — 2025
- Aerovate Therapeutics, Inc.Independent Board Director2023 — 2025Cambridge, Massachusetts, United States
- Albireo Pharma, Inc.Independent Board Director2022 — 2023Cambridge, Massachusetts, United States
- Acceleron PharmaPresident & CEO2016 — 2021Cambridge, Massachusetts
- MILLENDO THERAPEUTICSIndependent Board Director2018 — 2021Ann Arbor, Michigan
- Biotechnology Innovation OrganizationMember Board Of Directors2016 — 2017
- BayerPresident, U.S. Pharmaceuticals2015 — 2016Whippany, New Jersey
- BayerEVP, Global Head Specialty Medicine2013 — 2015Whippany, New Jersey
- BayerVP Ophthalmology & Global Launch Team Head - EYLEA®2010 — 2012Whippany, New Jersey
- BayerGlobal Head TA Neurology / Ophthalmology2008 — 2009Whippany, New Jersey
- BayerVP & Regional Business Unit Head2005 — 2008Berkeley, California
- BayerDirector, Int'l Sales & Marketing2003 — 2004Raleigh-Durham, North Carolina
- BayerHead of Strategic Planning2000 — 2002Osaka, Japan
- BayerArea Sales Manager1999 — 2000Atlantic Canada
- BayerProduct Manager / Management Trainee1997 — 1999Toronto, Canada
- BayerMedical Sales Representative1994 — 1997New Brunswick, Canada
Skills & more
Languages Arabic · English · Japanese
From Habib's professional profile.
Colleagues at RA Capital
Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adrian Bot
Venture Partner at RA Capital
Albert Kim
Advisor at RA Capital
Alex Miller
Senior Associate, Venture at RA Capital
Alex Zhang
Vice President, Structured Capital at RA Capital
Alison Tisdale
Advisor at RA Capital
Alyssa Larson
Investor at RA Capital
Frequently asked questions
- Who is Habib Dable?
- Habib Dable is an Advisor at Raven, where he advises and supports new companies, portfolio companies, and executives. He previously spent five years as President and CEO of Acceleron Pharma, which was acquired by Merck in 2021, and earlier held leadership roles over roughly 22 years at Bayer AG, including President, U.S. Pharmaceuticals. He holds a BBA and MBA from the University of New Brunswick and completed executive programs at Stanford University and Korn/Ferry.
- Where does Habib Dable work?
- Habib Dable is Advisor at RA Capital.
- What does Habib Dable invest in?
- Habib Dable invests in Biotech.
- What check size does Habib Dable write?
- Habib Dable typically writes checks of $100K – $5M.
- Where did Habib Dable go to school?
- Habib Dable studied at University of New Brunswick (Master of Business Administration - MBA, 1994); University of New Brunswick (Bachelor of Business Administration - BBA, 1991); Stanford University Graduate School of Business (Stanford Executive Program, 2007).
Same school
Also attended University of New Brunswick35
Desh DeshpandeSpecial Advisor at Data Point CapitalJeffrey MoorePresident at MC Healthcare VenturesLaila ThériaultInvestment Analyst at New Brunswick Innovation FoundationMeaghan SeagraveExecutive Director at Bioindustrial Innovation CanadaNelson SwitzerCo-Founder and Managing Partner at Climate Innovation CapitalFunke YusufFinance & Operations Specialist at New Brunswick Innovation Foundation
+ 29 more
Also attended Stanford University Graduate School of Business2,000
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberPeter FentonGeneral Partner at BenchmarkSteve JurvetsonCo-founder of Future VenturesDavid SzeAdvisory Partner at GreylockKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Hunter WalkCo-founder & Partner at Homebrew
+ 1,994 more
Shared employers
Also worked at Tyra Biosciences3
Also worked at Relay Therapeutics13
Anneli MathesonExecutive Assistant at Prelude VenturesJulia PianSenior Associate at Atlas VentureEli CasdinChief Investment Officer and Founder at Casdin CapitalDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesKori RahaimSenior Vice President, Head of People and 4:59 Initiative Business Operations at 5AM VenturesJakob LovenPartner at Nextech Invest
+ 7 more
